{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T23:29:23Z","timestamp":1773358163216,"version":"3.50.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To quantify the amount of silicone oil in intravitreal anti\u2013vascular endothelial growth factor and complement inhibitor injections in prefilled and commercial syringes (silicone-lubricated and silicone-free).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Patients deemed clinically appropriate to receive one of five intravitreal medications received the recommended dose. Syringes were overfilled such that 0.01-0.04 mL remained after injection for analysis. Aflibercept and ranibizumab were available in prefilled syringes. Pegcetacoplan, faricimab, and avacincaptad pegol were prepared with Becton Dickinson polycarbonate (BD) syringes. Faricimab was also prepared in Ocuject VitreJect (OV) silicone-free syringes. Samples were analyzed using spectral flow cytometry.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Silicone oil was found in all syringes. The lowest amounts of silicone oil were found in the Mili-Q water in OV syringes (4.02 \u00b1 0.3 particles per microliter) and ranibizumab 0.5 mg prefilled syringes (8.33 \u00b1 3.1). Intermediate levels of silicone oil were detected in aflibercept prefilled syringes (35.5 \u00b1 21.8) and faricimab in OV syringes (74.6 \u00b1 10.1), significantly greater than Mili-Q water in OV syringes and ranibizumab. Significantly higher levels of silicone oil were found with faricimab (324.9 \u00b1 30), pegcetacoplan (378.1 \u00b1 379.6), and avacincaptad pegol (113.5 \u00b1 14) in BD syringes than the low or intermediate groups. The filter needles used to draw up medications from vials likely contributed to the amount of silicone oil detected in the samples.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Commonly used BD polycarbonate syringes for intravitreal injections caused significantly higher levels of silicone oil to be injected into the eye than prefilled or silicone-free syringes. Repeated injections with more viscous intravitreal drugs increase the amount of silicone oil in the vitreous, leading to symptomatic floaters.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004512","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T15:01:54Z","timestamp":1747148514000},"page":"1744-1750","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["SILICONE OIL MICRODROPLETS FROM SYRINGES WITH INTRAVITREAL ANTI\u2013VASCULAR ENDOTHELIAL GROWTH FACTOR AND COMPLEMENT INHIBITOR INJECTIONS"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3141-6573","authenticated-orcid":false,"given":"Libby","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, Maryland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, Maryland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxuan","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Retina Specialists, Towson, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250822","doi-asserted-by":"crossref","first-page":"e1366","DOI":"10.1111\/aos.14838","article-title":"Silicone oil-free syringes, siliconized syringes and needles: quantitative assessment of silicone oil release with drugs used for intravitreal injection","volume":"99","author":"Melo","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"R2-20250822","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/2474126417735963","article-title":"Silicone oil droplets are more common in fluid from BD insulin syringes as compared to other syringes","volume":"1","author":"Emerson","year":"2017","journal-title":"J VitreoRetinal Dis"},{"key":"R3-20250822","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/s41433-020-0800-9","article-title":"Agitation of the syringe and release of silicone oil","volume":"34","author":"Dias J\u00fanior","year":"2020","journal-title":"Eye (Lond)."},{"key":"R4-20250822","doi-asserted-by":"crossref","first-page":"119704","DOI":"10.1016\/j.ijpharm.2020.119704","article-title":"Do not flick or drop off-label use plastic syringes in handling therapeutic proteins before administration","volume":"587","author":"Kim","year":"2020","journal-title":"Int J Pharm"},{"key":"R5-20250822","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40942-019-0184-9","article-title":"Prevalence of silicone oil droplets in eyes treated with intravitreal injection","volume":"5","author":"Melo","year":"2019","journal-title":"Int J Retina Vitreous"},{"key":"R6-20250822","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.oret.2020.07.021","article-title":"Prospective study of silicone oil microdroplets in eyes receiving intravitreal anti-vascular endothelial growth factor therapy in 3 different syringes","volume":"5","author":"Thompson","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"R7-20250822","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3928\/23258160-20190503-05","article-title":"Inflammatory reaction after aflibercept intravitreal injections associated with silicone oil droplets released from syringes: a case-control study","volume":"50","author":"Melo","year":"2019","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R8-20250822","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40942-023-00523-3","article-title":"Anti-complement drugs for the treatment of geographic atrophy and the release of silicone oil","volume":"10","author":"Melo","year":"2024","journal-title":"Int J Retina Vitreous"},{"key":"R9-20250822","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jamaophthalmol.2023.4326","article-title":"Presumed silicone oil droplets after intravitreal pegcetacoplan injections","volume":"141","author":"Dessouki","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"R10-20250822","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/jamaophthalmol.2023.3495","article-title":"Multiple small floaters associated with silicone oil droplets following intravitreal pegcetacoplan injection","volume":"141","author":"Bijon","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"R11-20250822","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.xphs.2019.05.018","article-title":"Characterization of protein aggregates, silicone oil droplets, and protein-silicone interactions using imaging flow cytometry","volume":"109","author":"Probst","year":"2020","journal-title":"J Pharm Sci"},{"key":"R12-20250822","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ab.2010.12.008","article-title":"Flow cytometry: a promising technique for the study of silicone oil-induced particulate formation in protein formulations","volume":"410","author":"Ludwig","year":"2011","journal-title":"Anal Biochem"},{"key":"R13-20250822","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40942-018-0153-8","article-title":"Release of silicone oil droplets from syringes","volume":"5","author":"Melo","year":"2019","journal-title":"Int J Retina Vitreous"},{"key":"R14-20250822","doi-asserted-by":"crossref","first-page":"882013","DOI":"10.3389\/fopht.2022.882013","article-title":"A silicone oil-free syringe tailored for intravitreal injection of biologics","volume":"2","author":"Gj\u00f8lberg","year":"2022","journal-title":"Front Ophthalmol"},{"key":"R16-20250822","article-title":"Urgent Field Safety Notice Custom Procedure Trays (CPTs) for ophthalmology containing affected syringes and needles from BD Information on Affected Devices. Published online","year":"2021"},{"key":"R17-20250822","article-title":"Field safety notice-march 2021 Immediate Attention required BVI's CustomEyes \u00ae kits and Malosa \u00ae kits containing BD syringes and\/or needles. Published online","year":"2021"},{"key":"R18-20250822","article-title":"Urgent: Field safety notice Aseptic medical Devices (AMD) sterile Transfer sets and Accessories FSCA-Identifier-2021\/01 type of Action-Field safety Corrective Action. Published online","year":"2021"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T21:00:27Z","timestamp":1755896427000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004512","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}